|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Gu MJ, Huang QC, Bao CZ, Li YJ, Li XQ, Ye
D, Ye ZH, Chen K and Wang JB: Attributable causes of colorectal
cancer in China. BMC Cancer. 18(38)2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Cheng L, Eng C, Nieman LZ, Kapadia AS and
Du XL: Trends in colorectal cancer incidence by anatomic site and
disease stage in the United States from 1976 to 2005. Am J Clin
Oncol. 34:573–580. 2011.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Vinson KE, George DC, Fender AW, Bertrand
FE and Sigounas G: The notch pathway in colorectal cancer. Int J
Cancer. 138:1835–1842. 2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Geissler K and Zach O: Pathways involved
in Drosophila and human cancer development: The notch,
hedgehog, wingless, runt, and trithorax pathway. Ann Hematol.
91:645–669. 2012.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Machida T, Fujita T, Ooo ML, Ohira M,
Isogai E, Mihara M, Hirato J, Tomotsune D, Hirata T, Fujimori M, et
al: Increased expression of proapoptotic BMCC1, a novel gene with
the BNIP2 and Cdc42GAP homology (BCH) domain, is associated with
favorable prognosis in human neuroblastomas. Oncogene.
25:1931–1942. 2006.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Pan CQ and Low BC: Functional plasticity
of the BNIP-2 and Cdc42GAP Homology (BCH) domain in cell signaling
and cell dynamics. FEBS Lett. 586:2674–2691. 2012.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Tatsumi Y, Takano R, Islam MS, Yokochi T,
Itami M, Nakamura Y and Nakagawara A: BMCC1, which is an
interacting partner of BCL2, attenuates AKT activity, accompanied
by apoptosis. Cell Death Dis. 6(e1607)2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Soh UJ and Low BC: BNIP2 extra long
inhibits RhoA and cellular transformation by Lbc RhoGEF via its BCH
domain. J Cell Sci. 121:1739–1749. 2008.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zhao LR, Tian W, Wang GW, Chen KX and Yang
JL: The prognostic role of PRUNE2 in leiomyosarcoma. Chin J Cancer.
32:648–652. 2013.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Price ND, Trent J, El-Naggar AK, Cogdell
D, Taylor E, Hunt KK, Pollock RE, Hood L, Shmulevich I and Zhang W:
Highly accurate two-gene classifier for differentiating
gastrointestinal stromal tumors and leiomyosarcomas. Proc Natl Acad
Sci USA. 104:3414–3419. 2007.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Cancer Genome Atlas Network. Comprehensive
molecular characterization of human colon and rectal cancer.
Nature. 487:330–337. 2012.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Vaidyanathan S, Cato K, Tang L, Pavey S,
Haass NK, Gabrielli BG and Duijf PH: In vivo overexpression of Emi1
promotes chromosome instability and tumorigenesis. Oncogene.
35:5446–5455. 2016.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kazemi T, Younesi V, Jadidi-Niaragh F and
Yousefi M: Immunotherapeutic approaches for cancer therapy: An
updated review. Artif Cells Nanomed Biotechnol. 44:769–779.
2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Salameh A, Lee A, Cardó-Vila M, Nunes DN,
Efstathiou E, Staquicini FI, Dobroff AS, Marchiò S, Navone NM,
Hosoya H, et al: PRUNE2 is a human prostate cancer suppressor
regulated by the intronic long noncoding RNA PCA3. Proc Natl Acad
Sci USA. 112:8403–8408. 2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Potkin SG, Guffanti G, Lakatos A, Turner
JA, Kruggel F, Fallon JH, Saykin AJ, Orro A, Lupoli S, Salvi E, et
al: Hippocampal atrophy as a quantitative trait in a genome-wide
association study identifying novel susceptibility genes for
Alzheimer's disease. PLoS One. 4(e6501)2009.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Iwama E, Tsuchimoto D, Iyama T, Sakumi K,
Nakagawara A, Takayama K, Nakanishi Y and Nakabeppu Y:
Cancer-related PRUNE2 protein is associated with nucleotides and is
highly expressed in mature nerve tissues. J Mol Neurosci.
44:103–114. 2011.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Harris JL, Richards RS, Chow CW, Lee S,
Kim M, Buck M, Teng L, Clarke R, Gardiner RA and Lavin MF: BMCC1 is
an AP-2 associated endosomal protein in prostate cancer cells. PLoS
One. 8(e73880)2013.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Quintanilha JCF, Wang J, Sibley AB, Xu W,
Espin-Garcia O, Jiang C, Etheridge AS, Ratain MJ, Lenz HJ,
Bertagnolli M, et al: Genome-wide association studies of survival
in 1520 cancer patients treated with bevacizumab-containing
regimens. Int J Cancer. 150:279–289. 2022.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Yang JL, Cogdell D, Eddy J, Trent J, Price
N and Zhang W: Expression of PRUNE2 mRNA and its positive
correlation with non-coding RNA PCA3 in leiomyosarcoma. Zhonghua
Zhong Liu Za Zhi. 34:497–500. 2012.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
22
|
Islam MR, Takano R, Yokochi T, Akter J,
Nakamura Y, Nakagawara A and Tatsumi Y: Programmed expression of
pro-apoptotic BMCC1 during apoptosis, triggered by DNA damage in
neuroblastoma cells. BMC Cancer. 19(542)2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Islam MS, Tatsumi Y, Takano R, Yokochi T,
Akter J, Ozaki T, Nakamura Y, Ohira M and Nakagawara A:
Transcriptional regulation of BMCC1 mediated by E2F1 in
neuroblastoma cells. Biochem Biophys Res Commun. 478:81–86.
2016.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Clarke RA, Zhao Z, Guo AY, Roper K, Teng
L, Fang ZM, Samaratunga H, Lavin MF and Gardiner RA: New genomic
structure for prostate cancer specific gene PCA3 within BMCC1:
Implications for prostate cancer detection and progression. PLoS
One. 4(e4995)2009.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Su SC, Yeh CM, Lin CW, Hsieh YH, Chuang
CY, Tang CH, Lee YC and Yang SF: A novel melatonin-regulated lncRNA
suppresses TPA-induced oral cancer cell motility through
replenishing PRUNE2 expression. J Pineal Res.
71(e12760)2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Bozgeyik E, Kocahan S, Temiz E and Bagis
H: miR-19a and miR-421 target PCA3 long non-coding RNA and restore
PRUNE2 tumor suppressor activity in prostate cancer. Mol Biol Rep:
Nov 27, 2021 (Epub ahead of print). doi:
10.1007/s11033-021-06996-5.
|
|
27
|
Masuda M, Hirakawa N, Nakashima T,
Kuratomi Y and Komiyama S: Cyclin D1 overexpression in primary
hypopharyngeal carcinomas. Cancer. 78:390–395. 1996.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Bayat Z, Ghaemi Z, Behmanesh M and Soltani
BM: Hsa-miR-186-5p regulates TGFβ signaling pathway through
expression suppression of SMAD6 and SMAD7 genes in colorectal
cancer. Biol Chem. 402:469–480. 2021.PubMed/NCBI View Article : Google Scholar
|
